glp-1 receptor agonists and cardiovascular outcome trials an update GLP-1 receptor agonist-based therapies and cardiovascular risk: a review of mechanisms in: Journal of Endocrinology Volume 263 Issue 1 (2024) Cardiovascular, mortality, and kidney outcomes
Pay in 4 interest-free payments of $7.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
00203-5/asset/a8f69d17-d3be-493d-a403-9e1bd60f380c/main.assets/gr4_lrg.jpg)

30249-9/asset/ae163e52-907c-4c99-987f-36b369e8996a/main.assets/gr3.gif)





















